Functional and Anatomical Visual Investigations in Patients With Early Forms of Age-related Macular Degeneration
Condition(s) studied
Study summary
Age-related macular degeneration (AMD) is the leading cause of visual impairment in industrialized countries. Anatomical examination findings at the early and intermediate stages of AMD are not sufficient to determine any functional alterations at these stages (e.g., alterations in microperimetry, multifocal electroretinogram (mfERG) and contrast sensitivity). Identifying early functional markers of the disease is a necessary first step in the development and clinical validation of treatments to slow progression to advanced disease.
Eligibility
Primary outcome measure(s)
- AMD evolution at 4 years — Year 4
AMD is considered to have progressed if, after 4 years, the patient has developed an advanced form of the disease. The onset of an advanced form is defined by the appearance of macular neovascularization (of any type), visible on fundus or OCT/OCT-A, or by the appearance of macular atrophy visible on fundus, autofluorescence or OCT.
Trial sites (1)
| Facility | City | Region | Status |
|---|---|---|---|
| Hôpital Fondation A. de Rothschild | Paris | France | Recruiting |
More Fondation Ophtalmologique Adolphe de Rothschild trials in France
Other trials for the same condition
This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.
View NCT06694272 on ClinicalTrials.gov ↗ ← All trials in France